General Information of Drug Off-Target (DOT) (ID: OTUH9JPD)

DOT Name Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1)
Synonyms Adapter protein X11alpha; Neuron-specific X11 protein; Neuronal Munc18-1-interacting protein 1; Mint-1
Gene Name APBA1
Related Disease
Adenocarcinoma ( )
Adenoma ( )
Alzheimer disease ( )
Carcinoma ( )
Colorectal carcinoma ( )
Cytomegalovirus infection ( )
Familial adenomatous polyposis ( )
Hereditary nonpolyposis colon cancer ( )
Neoplasm ( )
Schizophrenia ( )
Stomach cancer ( )
Ulcerative colitis ( )
Gastrointestinal stromal tumour ( )
Kaposi sarcoma ( )
UniProt ID
APBA1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1AQC; 1U37; 1U38; 1U39; 1U3B; 1X11; 1X45; 1Y7N
Pfam ID
PF00595 ; PF00640
Sequence
MNHLEGSAEVEVTDEAAGGEVNESVEADLEHPEVEEEQQQPPQQQHYVGRHQRGRALEDL
RAQLGQEEEERGECLARSASTESGFHNHTDTAEGDVIAAARDGYDAERAQDPEDESAYAV
QYRPEAEEYTEQAEAEHAEATHRRALPNHLHFHSLEHEEAMNAAYSGYVYTHRLFHRGED
EPYSEPYADYGGLQEHVYEEIGDAPELDARDGLRLYEQERDEAAAYRQEALGARLHHYDE
RSDGESDSPEKEAEFAPYPRMDSYEQEEDIDQIVAEVKQSMSSQSLDKAAEDMPEAEQDL
ERPPTPAGGRPDSPGLQAPAGQQRAVGPAGGGEAGQRYSKEKRDAISLAIKDIKEAIEEV
KTRTIRSPYTPDEPKEPIWVMRQDISPTRDCDDQRPMDGDSPSPGSSSPLGAESSSTSLH
PSDPVEASTNKESRKSLASFPTYVEVPGPCDPEDLIDGIIFAANYLGSTQLLSDKTPSKN
VRMMQAQEAVSRIKMAQKLAKSRKKAPEGESQPMTEVDLFISTQRIKVLNADTQETMMDH
PLRTISYIADIGNIVVLMARRRMPRSNSQENVEASHPSQDGKRQYKMICHVFESEDAQLI
AQSIGQAFSVAYQEFLRANGINPEDLSQKEYSDLLNTQDMYNDDLIHFSKSENCKDVFIE
KQKGEILGVVIVESGWGSILPTVIIANMMHGGPAEKSGKLNIGDQIMSINGTSLVGLPLS
TCQSIIKGLKNQSRVKLNIVRCPPVTTVLIRRPDLRYQLGFSVQNGIICSLMRGGIAERG
GVRVGHRIIEINGQSVVATPHEKIVHILSNAVGEIHMKTMPAAMYRLLTAQEQPVYI
Function
Putative function in synaptic vesicle exocytosis by binding to Munc18-1, an essential component of the synaptic vesicle exocytotic machinery. May modulate processing of the amyloid-beta precursor protein (APP) and hence formation of APP-beta. Component of the LIN-10-LIN-2-LIN-7 complex, which associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules.
Tissue Specificity Brain and spinal cord. Isoform 2 is expressed in testis and brain, but not detected in lung, liver or spleen.
Reactome Pathway
Neurexins and neuroligins (R-HSA-6794361 )
Assembly and cell surface presentation of NMDA receptors (R-HSA-9609736 )
Dopamine Neurotransmitter Release Cycle (R-HSA-212676 )

Molecular Interaction Atlas (MIA) of This DOT

14 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Adenocarcinoma DIS3IHTY Strong Posttranslational Modification [1]
Adenoma DIS78ZEV Strong Genetic Variation [2]
Alzheimer disease DISF8S70 Strong Biomarker [3]
Carcinoma DISH9F1N Strong Biomarker [4]
Colorectal carcinoma DIS5PYL0 Strong Posttranslational Modification [5]
Cytomegalovirus infection DISCEMGC Strong Biomarker [6]
Familial adenomatous polyposis DISW53RE Strong Biomarker [7]
Hereditary nonpolyposis colon cancer DISPA49R Strong Biomarker [8]
Neoplasm DISZKGEW Strong Biomarker [9]
Schizophrenia DISSRV2N Strong Genetic Variation [10]
Stomach cancer DISKIJSX Strong Biomarker [11]
Ulcerative colitis DIS8K27O Strong Biomarker [12]
Gastrointestinal stromal tumour DIS6TJYS moderate Posttranslational Modification [13]
Kaposi sarcoma DISC1H1Z Disputed Genetic Variation [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [14]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [20]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [15]
Triclosan DMZUR4N Approved Triclosan decreases the expression of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [16]
Methotrexate DM2TEOL Approved Methotrexate increases the expression of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [17]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [18]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [19]
Trichostatin A DM9C8NX Investigative Trichostatin A decreases the expression of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [21]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1). [22]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.Oncogene. 2004 Jun 3;23(26):4646-54. doi: 10.1038/sj.onc.1207588.
2 Case-control study of candidate gene methylation and adenomatous polyp formation.Int J Colorectal Dis. 2017 Feb;32(2):183-192. doi: 10.1007/s00384-016-2688-1. Epub 2016 Oct 22.
3 Expression of the neuronal adaptor protein X11alpha protects against memory dysfunction in a transgenic mouse model of Alzheimer's disease.J Alzheimers Dis. 2010;20(1):31-6. doi: 10.3233/JAD-2009-1341.
4 Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas.Gastroenterology. 2003 May;124(5):1300-10. doi: 10.1016/s0016-5085(03)00278-6.
5 Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype.Tumour Biol. 2011 Aug;32(4):653-9. doi: 10.1007/s13277-011-0165-6. Epub 2011 Apr 6.
6 NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.Acta Neuropathol. 2008 Dec;116(6):603-14. doi: 10.1007/s00401-008-0437-4. Epub 2008 Oct 3.
7 Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors.Mol Carcinog. 2008 Jan;47(1):1-8. doi: 10.1002/mc.20363.
8 Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.Fam Cancer. 2004;3(2):101-7. doi: 10.1023/B:FAME.0000039861.30651.c8.
9 Concordant DNA methylation in synchronous colorectal carcinomas.Cancer Prev Res (Phila). 2009 Sep;2(9):814-22. doi: 10.1158/1940-6207.CAPR-09-0054. Epub 2009 Sep 8.
10 Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.Am J Hum Genet. 2019 Aug 1;105(2):334-350. doi: 10.1016/j.ajhg.2019.06.012.
11 Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.Am J Pathol. 2002 Mar;160(3):787-94. doi: 10.1016/S0002-9440(10)64901-2.
12 Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.Am J Gastroenterol. 2010 Jul;105(7):1610-9. doi: 10.1038/ajg.2010.22. Epub 2010 Feb 16.
13 Aberrant methylation status of known methylation-sensitive CpG islands in gastrointestinal stromal tumors without any correlation to the state of c-kit and PDGFRA gene mutations and their malignancy.Cancer Sci. 2008 Feb;99(2):253-9. doi: 10.1111/j.1349-7006.2007.00682.x.
14 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
15 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
16 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
17 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
18 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
19 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
20 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
21 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
22 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.